Compass Pathways highlights for Q1 include two new patents and reports its Phase IIb clinical trial is on track.
Articles
Some people with color blindness report improved color vision after psychedelic drug use
A new report published in Drug Science, Policy and Law suggests that psychedelic drugs may improve symptoms of color blindness.
Minnesota Marijuana Legalization Bill Sponsor Expects GOP Support In House Floor Vote This Week
Getting a bill to legalize marijuana in Minnesota to the House floor has been no small task.
Are Millennials Missing An Opportunity With Psychedelic Stocks?
Psychedelic drug stocks are a very progressive investing option for investors seeking high-growth opportunities. So why aren't more Millennials jumping on the bandwagon?
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
Optimi Health and Numinus Wellness announce a new milestone in their partnership to develop an all-natural psilocybin extract.
Starting A Business? Study Finds Marijuana May Help—And Hinder
A new study out of Washington State University suggests cannabis may inspire entrepreneurs to come up with big, bold business ideas—but could also lead them down a rabbit hole of wishful thinking.
Molly, Psychedelic Drug, Shows Great Promise As Mental Health Treatment, New Study Finds
A couple hours after taking his first dose of the mind-altering drug 3,4-methylenedioxymethamphetamine, or MDMA, Bessel Van Der Kolk lay down on a couch in the presence of two psychotherapists, put on an eyeshade, and allowed himself to sink into a quiet, hypnotic state.
Wesana Health Commences Trading on the CSE
Wesana Health commences trading on the CSE, symbol "WESA".
(VIDEO) Minnesota Marijuana Legalization Bill Could ‘Absolutely’ Pass Full Legislature If GOP Senate Allows A Vote, Sponsor Says
A bill to legalize marijuana in Minnesota is set for a House floor vote this week, and the sponsor of the legislation is optimistic that it could pass the full legislature controlled Senate would just allow a vote on it.
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.
It’s been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds.
Psychedelic Stocks Slumber As Investors Sleep Through News
Lots of company news. Lots of industry news. Lots of new capital. But no investors. At the moment, they're busy GAMBLING.
Alabama Approves Medical Cannabis Legalization
Alabama lawmakers sent a medical cannabis legalization bill to Gov. Kay Ivy on Thursday that will allow qualifying patients to purchase certain forms of cannabis after receiving a doctor’s recommendation, according to the Associated Press.
Field Trip Health Ltd. Announces DTC Eligibility
Field Trip is now eligible for clearing and settlement through the DTC, boosting liquidity in the stock.
Alabama Medical Marijuana Bill Heads To Governor’s Desk Following Legislature’s Approval
A bill to legalize medical marijuana in Alabama is headed to the governor’s desk following its passage by the legislature.
Texas House Approves Psychedelics Research Bill As Marijuana Reform Measures Also Advance
The Texas House of Representatives on Thursday approved to a bill that would require the state to conduct a study into the therapeutic potential of psychedelics like psilocybin and MDMA.